25 September 2022
Cardiovascular disease is a growing burden and one of the leading causes of death in Bangladesh. In most cases, the exact cause of CVD is not known, but a combination of factors can increase the risk of getting heart disease.
Considering the risk factors associated with heart disease, DBL Pharma has celebrated “World Heart Day 2022” by arranging a scientific seminar on “Residual Risk in management of lipid to reduce cardiovascular diseases” at Hotel Radisson Blu on 23 September 2022.
The seminar is chaired by eminent Professor (Dr.) AKM Mohibullah (President, Bangladesh Cardiac Society), and the key topic was presented by renowned Cardiologist Prof. (Dr.) Abdullah Al Shafi Majumder (Secretary General, Bangladesh Cardiac Society) in the presence of distinguished physicians from different dimensions of Cardiology, Medicine, Diabetology, Endocrinology, Nephrology etc.
Prof. Dr. Shamim Ahmed, Prof. Dr. Syed Ali Ahsan, Prof. Dr. Khaled Mohsin, Prof. Dr. Mir Jamal Uddin, Prof. Dr. Abdul Wadud Chowdhury, Prof. Dr. Md. Khalequzzaman, Prof. Dr. A K M Manzurul Alam, Prof. Dr. Indrajit Prasad were present as expert panelist.
Prof. (Dr.) A A Shafi Majumder explained all the less addressed residual risk factors for cardiovascular diseases & its management and the expert panelists discussed it, which will definitely play an important role in reducing the burden of cardiovascular diseases in Bangladesh. As a scientific partner, DBL Pharma will continue this type of program and is passionate to use its heart to care every heart of the people.
Cardiovascular disease is a growing burden and one of the leading causes of death in Bangladesh. In most cases, the exact cause of CVD is not known, but a combination of factors can increase the risk of getting heart disease. Considering the risk factors associated with heart disease, DBL Pharma has celebrated “World Heart Day… Continue reading DBL Pharma celebrates World Heart Day 2022
DBL Pharmaceuticals Ltd. recently held its 1st Annual Business Conference at Hotel Sea Palace, Cox’s Bazar on 5th January 2023. DBL Pharma marked this conference to align its field force with a crafted vision of serving humanity by providing high-quality and differentiated medicines. Deputy Managing Director & Group CEO Mr. M. A. Quader inaugurated the… Continue reading DBL Pharma holds its 1st Annual Business Conference
DBL Pharma Hosts 2nd Annual Business Conference
DBL Pharmaceuticals Ltd. convened its highly anticipated 2nd Annual Business Conference at the prestigious Hotel Sea Palace. The event served as a pivotal moment for DBL Pharma, rallying its dedicated field force around a shared commitment to delivering unparalleled quality and innovative medicines to humanity. The conference was inaugurated by Mr. Abdul Wahed, Chairman, DBL… Continue reading DBL Pharma Hosts 2nd Annual Business Conference